Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Biotechnology

Healthcare
$4.16 +2.94%

+$0.14 today

Market cap
$120.02M
Beta
0.29
P/E (TTM)
-3.0
EPS (TTM)
-$1.66
52W Low $3.20High $12.99

Volume 0.27M

Average 0.08M

NTHI Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Neonc Technologies Holdings, Inc.NASDAQ: NTHI

Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Financing cash flow declines year over year

Q1 FY2026 financing cash flow of $7.07M fell 35.9% year over year. Sequentially, it rose 168.2% from the prior quarter.

Context

  • Financing cash flow amounted to 52157.5% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.07M+168.2% QoQ
Last fiscal yearDec 2025
$20.86M— YoY
LTMMar 2026
$16.91M— YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-35.9%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
20.86M USD
Year-over-year change
—

Financing Cash Flow vs competitors

How NTHI compares with its peers on the latest reported figures

No competitor Financing Cash Flow figures are available to compare.

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Intrinsic Alpha fair value

Locked

Current Price

$4.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.